Cevec Pharmaceuticals

BiotechnologySeries CCologne, Germanycevec.com

Latest round

Series C

Last raised

Jul 2015

Total raised

$22M

Investors

7

About Cevec Pharmaceuticals

Founded in 2003, Cevec Pharmaceuticals GmbH is based in Cologne, Germany, focusing on the development and production of biologics.50 mn.Cevec specializes in advanced biomanufacturing solutions, particularly focusing on the development and production of biologics and therapeutic proteins. Their core offerings include a proprietary cell line technology that enables the efficient production of complex proteins crucial for the pharmaceutical industry. This technology enhances yield and reduces production time, addressing significant challenges faced by companies developing biologic medications. Cevec serves a diverse clientele that includes biotech companies and pharmaceutical firms across North America and Europe, specifically in Germany, the United States, and the United Kingdom.Cevec's revenue model is primarily based on B2B transactions through partnerships with pharmaceutical and biotechnology organizations. These partnerships often include licensing agreements and service contracts for the use of their proprietary technologies in biologic manufacturing. Clients may enter into multi-year contracts for continuous access to Cevec’s capabilities, facilitating ongoing production as they develop their therapeutic pipelines.In October 2022, Cytiva Software acquired Cevec Pharmaceuticals GmbH for an undisclosed amount, which allows Cytiva access to scalable production cell lines for vectors based on adeno-associated viruses and adenoviruses. Moving forward, Cevec plans to expand its product offerings and market presence.

Who invested in Cevec Pharmaceuticals

7 investors across 4 rounds

See all investors in Cevec Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jul 30, 2015

    Amount

    $4.9M

    Investors

    Locked

  2. Series C

    Oct 25, 2012

    Amount

    $3.6M

    Investors

    Locked

  3. Series E

    Jul 25, 2011

    Amount

    $8.5M

    Investors

    Locked

  4. Series D

    Dec 1, 2009

    Amount

    $5.4M

    Investors

    Locked

Questions about Cevec Pharmaceuticals

Who invested in Cevec Pharmaceuticals?

Cevec Pharmaceuticals has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cevec Pharmaceuticals raised?

Cevec Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Cevec Pharmaceuticals last raise money?

Cevec Pharmaceuticals's most recent round on record is a Series C, in Jul 2015.

What does Cevec Pharmaceuticals do?

Founded in 2003, Cevec Pharmaceuticals GmbH is based in Cologne, Germany, focusing on the development and production of biologics.

Where is Cevec Pharmaceuticals headquartered?

Cevec Pharmaceuticals is headquartered in Cologne, Germany.

Which VCs invest in companies like Cevec Pharmaceuticals?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Cevec Pharmaceuticals's stage. Their profiles are linked below.

Raising like Cevec Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.